共 26 条
- [1] Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study Journal of Clinical Immunology, 2021, 41 : 458 - 469
- [4] Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study Journal of Clinical Immunology, 2021, 41 : 66 - 75
- [9] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases Journal of Clinical Immunology, 2014, 34 : 204 - 211
- [10] Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency Journal of Clinical Immunology, 2010, 30 : 734 - 745